哈药股份：所属企业获得药品注册证书

Core Viewpoint - The company, Harbin Pharmaceutical Group Co., Ltd., has received approval for its Oseltamivir Phosphate Dry Suspension from the National Medical Products Administration, marking a significant regulatory milestone for the company [2] Group 1 - Harbin Pharmaceutical Group's subsidiary, Harbin Pharmaceutical Group Pharmaceutical Sixth Factory, has been granted a drug registration certificate for Oseltamivir Phosphate Dry Suspension [2] - The approval signifies the company's commitment to expanding its product portfolio in the pharmaceutical sector [2]